144 related articles for article (PubMed ID: 38104908)
1. Uveal melanoma modeling in mice and zebrafish.
van den Bosch QCC; de Klein A; Verdijk RM; Kiliç E; Brosens E;
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189055. PubMed ID: 38104908
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A
BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459
[TBL] [Abstract][Full Text] [Related]
4. BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors.
Han A; Purwin TJ; Bechtel N; Liao C; Chua V; Seifert E; Sato T; Schug ZT; Speicher DW; Harbour JW; Aplin AE
Oncogene; 2021 Jan; 40(3):618-632. PubMed ID: 33208912
[TBL] [Abstract][Full Text] [Related]
5. Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ
J Biol Chem; 2021; 296():100403. PubMed ID: 33577798
[TBL] [Abstract][Full Text] [Related]
6. Co-occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence.
Yu L; Zhou D; Zhang G; Ren Z; Luo X; Liu P; Plouffe SW; Meng Z; Moroishi T; Li Y; Zhang Y; Brown JH; Liu S; Guan KL
Mol Oncol; 2022 Feb; 16(3):607-629. PubMed ID: 34706158
[TBL] [Abstract][Full Text] [Related]
7. Verification of EZH2 as a druggable target in metastatic uveal melanoma.
Jin B; Zhang P; Zou H; Ye H; Wang Y; Zhang J; Yang H; Pan J
Mol Cancer; 2020 Mar; 19(1):52. PubMed ID: 32127003
[TBL] [Abstract][Full Text] [Related]
8. In-vivo imaging for assessing tumor growth in mouse models of ocular melanoma.
Zaks O; Gaber D; Ben-Yaakov K; Sharvit-Bader M; Goz A; Rotfogel Z; Ish-Shalom S; Kesler E; Yosepovich A; Leiba H; Jager MJ; Marcovich AL; Aharoni-Simon M
Exp Eye Res; 2021 Mar; 204():108431. PubMed ID: 33406396
[TBL] [Abstract][Full Text] [Related]
9. EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation.
Neumann LC; Weinhäusel A; Thomas S; Horsthemke B; Lohmann DR; Zeschnigk M
BMC Cancer; 2011 Aug; 11():380. PubMed ID: 21871071
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
11. Copper ionophore elesclomol selectively targets GNAQ/11-mutant uveal melanoma.
Li Y; Yang J; Zhang Q; Xu S; Sun W; Ge S; Xu X; Jager MJ; Jia R; Zhang J; Fan X
Oncogene; 2022 Jul; 41(27):3539-3553. PubMed ID: 35697803
[TBL] [Abstract][Full Text] [Related]
12. Uveal melanoma: Towards a molecular understanding.
Smit KN; Jager MJ; de Klein A; Kiliҫ E
Prog Retin Eye Res; 2020 Mar; 75():100800. PubMed ID: 31563544
[TBL] [Abstract][Full Text] [Related]
13. High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells.
Slater K; Heeran AB; Garcia-Mulero S; Kalirai H; Sanz-Pamplona R; Rahman A; Al-Attar N; Helmi M; O'Connell F; Bosch R; Portela A; Villanueva A; Gallagher WM; Jensen LD; Piulats JM; Coupland SE; O'Sullivan J; Kennedy BN
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066024
[TBL] [Abstract][Full Text] [Related]
14. Minimal contribution of ERK1/2-MAPK signalling towards the maintenance of oncogenic GNAQQ209P-driven uveal melanomas in zebrafish.
Mouti MA; Dee C; Coupland SE; Hurlstone AF
Oncotarget; 2016 Jun; 7(26):39654-39670. PubMed ID: 27166257
[TBL] [Abstract][Full Text] [Related]
15. YAP/TAZ Activation Drives Uveal Melanoma Initiation and Progression.
Li H; Li Q; Dang K; Ma S; Cotton JL; Yang S; Zhu LJ; Deng AC; Ip YT; Johnson RL; Wu X; Punzo C; Mao J
Cell Rep; 2019 Dec; 29(10):3200-3211.e4. PubMed ID: 31801083
[TBL] [Abstract][Full Text] [Related]
16. The AMP-dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma.
Chua V; Han A; Bechtel N; Purwin TJ; Hunter E; Liao C; Harbour JW; Aplin AE
Pigment Cell Melanoma Res; 2022 Jan; 35(1):78-87. PubMed ID: 34347929
[TBL] [Abstract][Full Text] [Related]
17. Role of immune checkpoint inhibitors and novel immunotherapies in uveal melanoma.
Jindal V
Chin Clin Oncol; 2018 Feb; 7(1):8. PubMed ID: 29486567
[TBL] [Abstract][Full Text] [Related]
18. Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma Cell Lines - A Pilot Study.
Herwig-Carl MC; Sharma A; Tischler V; Pelusi N; Loeffler KU; Holz FG; Zeschnigk M; Landreville S; Auw-Haedrich C; Noberini R; Bonaldi T
Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):27. PubMed ID: 38349785
[TBL] [Abstract][Full Text] [Related]
19. The unfolded protein response and the biology of uveal melanoma.
Zhang S; Wang K; Zhu X; Cherepanoff S; Conway RM; Madigan MC; Zhu L; Murray M; Zhou F
Biochimie; 2022 Jun; 197():9-18. PubMed ID: 35093452
[TBL] [Abstract][Full Text] [Related]
20. Modeling of human uveal melanoma in zebrafish xenograft embryos.
van der Ent W; Burrello C; Teunisse AF; Ksander BR; van der Velden PA; Jager MJ; Jochemsen AG; Snaar-Jagalska BE
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6612-22. PubMed ID: 25249605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]